The Cooper Companies, Inc. (NASDAQ:COO) Holdings Lifted by Woodline Partners LP

Woodline Partners LP increased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 1.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 562,500 shares of the medical device company’s stock after buying an additional 7,301 shares during the quarter. Woodline Partners LP owned 0.28% of Cooper Companies worth $51,711,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. Byrne Asset Management LLC purchased a new position in Cooper Companies in the fourth quarter valued at about $33,000. OFI Invest Asset Management purchased a new position in Cooper Companies in the fourth quarter valued at about $34,000. New Age Alpha Advisors LLC purchased a new position in Cooper Companies in the fourth quarter valued at about $38,000. Covestor Ltd grew its stake in Cooper Companies by 35.5% in the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company’s stock valued at $42,000 after purchasing an additional 120 shares in the last quarter. Finally, Atala Financial Inc purchased a new position in Cooper Companies in the fourth quarter valued at about $51,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Price Performance

NASDAQ COO opened at $81.91 on Tuesday. The Cooper Companies, Inc. has a twelve month low of $69.81 and a twelve month high of $112.38. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The stock has a market capitalization of $16.38 billion, a PE ratio of 42.01, a P/E/G ratio of 2.25 and a beta of 1.08. The stock has a 50-day simple moving average of $80.25 and a 200 day simple moving average of $89.83.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting the consensus estimate of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business had revenue of $964.70 million during the quarter, compared to analysts’ expectations of $981.25 million. Research analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analysts Set New Price Targets

COO has been the topic of a number of recent research reports. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research note on Friday, March 7th. BNP Paribas upgraded Cooper Companies to a “hold” rating in a research note on Thursday, March 13th. Robert W. Baird lowered their target price on Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a research note on Friday, March 7th. JPMorgan Chase & Co. lowered their target price on Cooper Companies from $120.00 to $110.00 and set an “overweight” rating on the stock in a research note on Friday, March 7th. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $115.00 price target (down previously from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Four investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $110.25.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.